Insights into the role of gut microbiota modulation in the management of various cardiovascular diseases: A new approach for improving the efficacy of current cardiovascular medications

Animals; Cardiovascular Agents; Cardiovascular Diseases; Dysbiosis; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Humans; Prebiotics; Probiotics; antibiotic agent; host factor; prebiotic agent; probiotic agent; trimethylamine; cardiovascular agent; probiotic agent; atherosclerosis; cardiovascular disease; cerebrovascular accident; controlled study; coronary artery disease; drug combination; drug response; drug therapy; dysbiosis; etiology; fecal microbiota transplantation; gut microbiome; heart failure; human; hypertension; intestine; intestine flora; male; metabolite; microflora; nonhuman; normal human; oral drug administration; pharmacodynamics; pharmacokinetics; pharmacology; quality of life; review; therapy; animal; drug effect; dysbiosis; microbiology